A detailed history of Nikko Asset Management Americas, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,576,261 shares of CDNA stock, worth $59.1 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
2,576,261
Previous 2,748,338 6.26%
Holding current value
$59.1 Million
Previous $29.1 Million 37.47%
% of portfolio
0.47%
Previous 0.29%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$7.56 - $16.15 $1.3 Million - $2.78 Million
-172,077 Reduced 6.26%
2,576,261 $40 Million
Q1 2024

May 02, 2024

SELL
$7.96 - $12.37 $1.01 Million - $1.57 Million
-126,561 Reduced 4.4%
2,748,338 $29.1 Million
Q4 2023

Feb 08, 2024

SELL
$4.9 - $12.86 $733,059 - $1.92 Million
-149,604 Reduced 4.95%
2,874,899 $34.5 Million
Q3 2023

Nov 09, 2023

BUY
$7.0 - $11.26 $611,646 - $983,876
87,378 Added 2.97%
3,024,503 $21.2 Million
Q2 2023

Aug 14, 2023

BUY
$7.61 - $9.46 $1.42 Million - $1.77 Million
186,657 Added 6.79%
2,937,125 $25 Million
Q1 2023

May 03, 2023

BUY
$8.83 - $17.61 $1.65 Million - $3.3 Million
187,308 Added 7.31%
2,750,468 $25.1 Million
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $826,869 - $1.52 Million
75,999 Added 3.06%
2,563,160 $29.2 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $5.05 Million - $8.29 Million
314,136 Added 14.46%
2,487,161 $40.7 Million
Q2 2022

Aug 04, 2022

BUY
$20.49 - $39.72 $4.22 Million - $8.17 Million
205,791 Added 10.46%
2,173,025 $30.4 Million
Q1 2022

May 06, 2022

BUY
$28.19 - $46.6 $13.1 Million - $21.7 Million
465,319 Added 30.98%
1,967,234 $70.8 Million
Q4 2021

Feb 08, 2022

BUY
$41.2 - $73.6 $16.8 Million - $30 Million
407,962 Added 37.29%
1,501,915 $66.6 Million
Q3 2021

Nov 09, 2021

SELL
$59.15 - $91.99 $4.46 Million - $6.94 Million
-75,463 Reduced 6.45%
1,093,953 $63.7 Million
Q2 2021

Aug 09, 2021

BUY
$63.02 - $95.11 $22.2 Million - $33.5 Million
352,604 Added 43.17%
1,169,416 $105 Million
Q1 2021

May 03, 2021

BUY
$57.62 - $95.6 $2.75 Million - $4.56 Million
47,749 Added 6.21%
816,812 $55.6 Million
Q4 2020

Feb 11, 2021

BUY
$41.43 - $77.09 $1.05 Million - $1.96 Million
25,388 Added 3.41%
769,063 $55.7 Million
Q3 2020

Nov 02, 2020

BUY
$30.88 - $37.94 $1.1 Million - $1.35 Million
35,535 Added 5.02%
743,675 $28 Million
Q2 2020

Aug 07, 2020

SELL
$18.95 - $35.43 $5.43 Million - $10.2 Million
-286,795 Reduced 28.83%
708,140 $19.1 Million
Q1 2020

Apr 30, 2020

BUY
$13.94 - $28.25 $5.38 Million - $10.9 Million
385,926 Added 63.37%
994,935 $21.7 Million
Q4 2019

Feb 06, 2020

BUY
$19.24 - $28.41 $6.56 Million - $9.68 Million
340,797 Added 127.06%
609,009 $13.1 Million
Q3 2019

Oct 29, 2019

BUY
$20.03 - $40.08 $5.37 Million - $10.7 Million
268,212 New
268,212 $6.06 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.23B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.